Zynerba Pharmaceuticals
$1.3
70
+$0.03+2.36% Tuesday 20:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
59.48M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
13NovExpected
Expected EPS
0.09
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-35.04MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ZYNE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II clinical trial for treating children and adolescent patients with autism spectrum disorder; is in Phase II clinical trial for treating pediatric behavioral and emotional symptoms of 22q11.2 deletion syndrome; and to treat children and adolescent patients with fragile X syndrome. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Devon, Pennsylvania.
Show more...
CEO
Armando Anido
Employees
26
Country
US
ISIN
US98986X1090
WKN
000A14XCV
Listings
0 Comments
Share your thoughts
FAQ
What is Zynerba Pharmaceuticals stock price today?▼
The current price of ZYNE is $1.3 USD — it has increased by +2.36% in the past 24 hours. Watch Zynerba Pharmaceuticals stock price performance more closely on the chart.
What is Zynerba Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Zynerba Pharmaceuticals stocks are traded under the ticker ZYNE.
What is Zynerba Pharmaceuticals market cap?▼
Today Zynerba Pharmaceuticals has the market capitalization of 59.48M
What is Zynerba Pharmaceuticals revenue for the last year?▼
Zynerba Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Zynerba Pharmaceuticals net income for the last year?▼
ZYNE net income for the last year is -35.04M USD.
How many employees does Zynerba Pharmaceuticals have?▼
As of April 10, 2026, the company has 26 employees.
In which sector is Zynerba Pharmaceuticals located?▼
Zynerba Pharmaceuticals operates in the Manufacturing sector.
When did Zynerba Pharmaceuticals complete a stock split?▼
Zynerba Pharmaceuticals has not had any recent stock splits.
Where is Zynerba Pharmaceuticals headquartered?▼
Zynerba Pharmaceuticals is headquartered in Devon, US.